INIS
patients
100%
cost
35%
surgery
33%
carcinomas
25%
risks
20%
values
19%
netherlands
16%
photodynamic therapy
15%
evaluation
15%
hospitals
14%
comparative evaluations
14%
economics
13%
design
13%
quality of life
12%
women
12%
interventions
11%
data
10%
children
10%
decision making
9%
uracils
8%
populations
8%
levels
8%
reviews
8%
cancer
8%
fluorouracils
7%
breasts
7%
cardiopulmonary resuscitation
7%
refractories
7%
adults
7%
surveys
7%
Keyphrases
Discrete Choice Experiment
37%
Netherlands
18%
Dutch
15%
Photodynamic Therapy
15%
Cost-effectiveness
13%
Superficial Basal Cell Carcinoma
13%
Patient Preference
13%
Imiquimod
12%
Irritable Bowel Syndrome
11%
Surgical Treatment
9%
Basal Cell Carcinoma
9%
Actinic Keratosis
9%
Non-inferiority Trial
8%
Out-of-hospital Cardiac Arrest
8%
Value-based Care
8%
Confidence Interval
7%
Fluorouracil
7%
5-fluorouracil (5-FU)
7%
Randomized Trial
7%
Quality-adjusted Life Years
7%
Methyl Aminolevulinate
6%
Topical Imiquimod
6%
Randomized Controlled Trial
6%
Extracorporeal Cardiopulmonary Resuscitation
6%
Atrial Fibrillation
6%
Economic Evaluation
6%
Surgical Excision
5%
Healthcare
5%
Multicenter Randomized Controlled Trial
5%
High Risk
5%
Medicine and Dentistry
Health Care Cost
19%
Fluorouracil
13%
Photochemotherapy
12%
Randomized Controlled Trial
11%
Imiquimod
11%
Patient Preference
10%
Cost-Effectiveness Analysis
10%
Atrial Fibrillation
10%
Noninferiority Trial
9%
Irritable Bowel Syndrome
9%
Aminolevulinic Acid Methyl Ester
9%
Resuscitation
8%
Quality of Life
8%
Out of Hospital Cardiac Arrest
8%
Superficial Basal Cell Carcinoma
6%
Basal-Cell Carcinoma
6%
Actinic Keratosis
6%
Extracorporeal
6%
Recurrent Disease
6%
